Ваша жизнь в ваших руках. Как понять, победить и предотвратить рак груди и яичников

72. www.cancersupportinternational.com

73. The Royal Commission on Environmental Pollution, 2003. Chemicals in products: safeguarding the environment and human health. Report 24; Annual Reports of the (UK) Chemical Stakeholders Forum, 2002, and The Advisory Committee on Hazardous Substances, 2002; Miller, WR. And Sharpe, P.M., 1998. Environmental oestrogens and human reproductive cancers. Endocrine-Related Cancer, 5, 69–96.

74. Charlier, C.C.J., 2002. Determination of organochlorine pesticide residues in the blood of healthy individuals. Clinical Chemistry and Laboratory Medicine, 44, 361–364; WWF, 2003. UK national biomonitoring survey. WWF.

75. MDuffie, H.H., 2005. Host factors and genetic susceptibility: a paradigm of the conundrum of pesticide exposure and cancer associations. Reviews on Environmental Health. 20 (2), 77-101.

76. Mathur, V, 2002. Breast cancer incidence and exposure to pesticides among women originating from Jaipur. Environment International, 28 (5), 331–336; Starek, A., 2003. Estrogen and organochlorine xenoestrogens and breast cancer risk. International Journal of Occupational Medicine and Environmental Health. 16 (2), 113–124.

77. Frigo, D.E., 2004. Mechanism of AP-1-mediated gene expression by select organochlorines through the p38 МАРК pathway. Carcinogenesis, 25 (Feb), 249–261; Lewis, J.S. and others, 2005. Differential effects of 16-hydroxyestrone and 2-meth-oxyestradiol on cyclin D1 involving the transcription factor ATF-2 in MCF-7 breast cancer cells. Journal of Molecular Endocrinology, 34, 91-105; Tessier, D.D., 2001. Increased ErbB-2 tyrosine kinase activity, МАРК phosporylation, and cell proliferation in the prostate cancer cell line LNCaP following treatment by select pesticides. Toxicological Sciences. 60 (1), 38–43.

78. Swan S.H. and others, 2005. Decrease in anogenital distance among male infants with prenatal phthalate exposure. Environmental Health Perspectives, 113, (8).

79. Kawauchi, H., 2002. Identification of growth hormone in the sea lamprey, an extant representative of a group of the most ancient vertebrates. Endocrinology, 143 (12), 4916–4921; Park, J.I., 2005. Conservation of the heterodimeric glycoprotein hormone subunit family proteins and the LGR signalling system from nematodes to humans. Endocrine Journal, 26 (3), 267–276.

80. Environmental Endocrine Disruptors: A Handbook of Property Data, John Wiley and Sons.

81. Edwards, T.T., 2006. Reproductive dysgenesis in wildlife: a comparative view. International Journal of Andrology, 29 (1), 109–121; Guillette, L.L., 1999. Plasma steroid concentrations and male phallus size in juvenile alligators from seven Florida lakes. General and Comparative Endocrinology, 116(3), 356–372.

82. Colborn, Т., Dumanoski, D. and Myers, J.P., 1996. Our Stolen Futures, Dutton, Penguin Books, USA.

83. Webb, S.F., 2000. Risk assessment approaches for Pharmaceuticals. In: International Seminar: Pharmaceuticals in the Environment, Technological Institute, Section on Environmental Technology, Brussels, 2000.

84. Kolpin, D.A., Furlong, E.T., Meyer, M.T., Thurman, E.M., Zaugg, S.D., Barber, L.B. and Buxton, H.T.; 2002. Pharmaceuticals, Hormones, and Other Organic Wastewater Contaminants in US Streams, 1999–2000: A National Reconnaissance. Environmental Science & Technology, 36, 1202–1211.

85. McQuillan, D., Mullany, J., Parker, J., Mills, D., Sherrell, K. and Chapman, Т.Н., 2000. Drug Residues in Ambient Water: Initial Surveillance in New Mexico, USA. December 2000 Progress Report,html; Morelli, J., 2000. Are Our Medicines Tainting the Environment?

http://webmd.lycos.com/content/article/25/1728_58159?

86. McQuillan, D., Mullany, J., Parker, J., Mills, D., Sherrell, K. and Chapman, Т.Н., 2000. Drug Residues in Ambient Water: Initial Surveillance in New Mexico, USA. December 2000 Progress Report,html

87. The Royal Commission on Environmental Pollution, 2003. Chemicals in products: safeguarding the environment and human health. Report 24.

88. Hamburger Umwelt Institute, 1997. Poor Design Practices – gaseous emissions form complex products.

89. Brown, S.K. and Cheng, M., 2000. Volatile Organic Compounds (VOCs) in New Car Interiors. Presented at the 35th International Clean Air & Environment Conference Sydney, 26–30 November 2000.

90. http://www.le.ac.uk/ieh

91. Clapp, R.W and others, 2005. Environmental and occupational causes of cancer. The Lowell Centre for Sustainable Production, University of Massachusetts Lowell.

92. The Globe and Mail, November 22, 2002, page A5. Data point to breast-cancer risk. By Martin Mittelstaedt.

93. Newby, JA. and Howard, C.V, 2006. Environmental influences in cancer aetiology. Journal of Nutritional and Environmental Medicine; 2006, 1-59.

94. Clapp, R.W and others, 2005. Environmental and occupational causes of cancer. The Lowell Centre for Sustainable Production, University of Massachusetts Lowell.

95. Birnbaum, L.S. and Fenton, S.E., 2003. Cancer and developmental exposure to endocrine disruptors. Environmental Health Perspectives, 11 (4), 389–395.

96. www.obgyn.nct/newsrx/womens_health-Colorectal_Cancer-20001214-7.asp

97.theepicstudy

98. www.ucdmc.ucdavis.edu/ucdhs/health/a-z/06BreastCancer/ doc06lowerisk.html

99. Epidem. 1994, 23 (6), 1133–1136.

100. Spurgeon, D., 2006. Vitamin D is associated with a lower risk of cancer. BMJ, 332, 70.

101. Miller, WR. and Sharpe, R.M., 1998. Environmental oestro-gens and human reproductive cancers. Endocrine-Related Cancer, 5, 69–96.

102. http://cis.nci.nih.gov/fact/3_13.htm

103. Gottlieb, Scott. 2002. Study supports evidence on oral contraception and breast cancer. BMJ, 325, 6 July 2002, 8.

104. Writing Group for the Women’s Health Initiative Investigators. 2002. Risks and Benefits of Estrogen Plus Progestin in Healthy Postmenopausal Women. Journal of the American Medical Association, 288, № 3.